Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1α

被引：186

作者：

Proost, P

Struyf, S

Schols, D

Durinx, C

Wuyts, A

Lenaerts, JP

De Clercq, E

De Meester, I

Van Damme, J

机构：

[1] Katholieke Univ Leuven, Rega Inst Med Res, Lab Mol Immunol, B-3000 Leuven, Belgium

[2] Katholieke Univ Leuven, Rega Inst Med Res, Lab Expt Chemotherapy, B-3000 Leuven, Belgium

[3] Univ Instelling Antwerp, Lab Clin Biochem, B-2610 Wilrijk, Belgium

来源：

FEBS LETTERS | 1998年 / 432卷 / 1-2期

关键词：

chemokine; CXCR4; HIV-1; inhibitor; desensitization; SDF-1; alpha; exopeptidase;

D O I：

10.1016/S0014-5793(98)00830-8

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The chemokine stromal-cell-derived factor-let (SDF-1 alpha) chemoattracts lymphocytes and CD34(+) haematopoietic progenitors and is the ligand for CXCR4 (CXC chemokine receptor 4), the main co-receptor for T-tropic HIV-1 strains. SDF-1 alpha was NH2-terminally cleaved to SDF-1 alpha?(3-68) by dipeptidyl-peptidase IV (CD26/DPP IV), which is present in blood in soluble and membrane-bound form. SDF-1 alpha(3-68) lost both lymphocyte chemotactic and CXCR4-signaling properties. However, SDF-1 alpha(3-68) still desensitized the SDF-1 alpha(1-68)-induced Ca2+ response. In contrast to CD26/DPP IV-processed RANTES(3-68), SDF-1 alpha(3-68) had diminished potency to inhibit HIV-I infection. Thus, CD26/DPP IV impairs the inflammatory and haematopoietic potency of chemokines but plays a dual role in AIDS. (C) 1998 Federation of European Biochemical Societies.

引用

页码：73 / 76

页数：4

共 38 条

[1] CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1
Alkhatib, G
Combadiere, C
Broder, CC
Feng, Y
Kennedy, PE
Murphy, PM
Berger, EA
[J]. SCIENCE, 1996, 272 (5270) : 1955 - 1958
[2] Human chemokines: An update
Baggiolini, M
Dewald, B
Moser, B
[J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 675 - 705
[3] The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
Bleul, CC
Farzan, M
Choe, H
Parolin, C
ClarkLewis, I
Sodroski, J
Springer, TA
[J]. NATURE, 1996, 382 (6594) : 829 - 833
[4] A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
Bleul, CC
Fuhlbrigge, RC
Casasnovas, JM
Aiuti, A
Springer, TA
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) : 1101 - 1109
[5] NEUTROPHILS CAN GENERATE THEIR ACTIVATOR NEUTROPHIL-ACTIVATING PEPTIDE-2 BY PROTEOLYTIC CLEAVAGE OF PLATELET-DERIVED CONNECTIVE TISSUE-ACTIVATING PEPTIDE-III
BRANDT, E
VANDAMME, J
FLAD, HD
[J]. CYTOKINE, 1991, 3 (04) : 311 - 321
[6] FORMATION OF NEUTROPHIL-ACTIVATING PEPTIDE-2 FROM PLATELET-DERIVED CONNECTIVE-TISSUE-ACTIVATING PEPTIDE-III BY DIFFERENT TISSUE PROTEINASES
CAR, BD
BAGGIOLINI, M
WALZ, A
[J]. BIOCHEMICAL JOURNAL, 1991, 275 : 581 - 584
[7] The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
Choe, H
Farzan, M
Sun, Y
Sullivan, N
Rollins, B
Ponath, PD
Wu, LJ
Mackay, CR
LaRosa, G
Newman, W
Gerard, N
Gerard, C
Sodroski, J
[J]. CELL, 1996, 85 (07) : 1135 - 1148
[8] CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128
[9] IDENTIFICATION OF RANTES, MIP-1-ALPHA, AND MIP-1-BETA AS THE MAJOR HIV-SUPPRESSIVE FACTORS PRODUCED BY CD8(+) T-CELLS
COCCHI, F
DEVICO, AL
GARZINODEMO, A
ARYA, SK
GALLO, RC
LUSSO, P
[J]. SCIENCE, 1995, 270 (5243) : 1811 - 1815
[10] Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1
Crump, MP
Gong, JH
Loetscher, P
Rajarathnam, K
Amara, A
Arenzana-Seisdedos, F
Virelizier, JL
Baggiolini, M
Sykes, BD
Clark-Lewis, I
[J]. EMBO JOURNAL, 1997, 16 (23) : 6996 - 7007

← 1 2 3 4 →